Assessing the Limits of Circularity in Healthcare Plastics

New research shows polycarbonate from bioprocessing devices can be recycled, challenging circularity limits in healthcare plastics.

Single-use plastics play a central role in modern bioprocessing. Disposable bioreactors, tubing sets, and vessels reduce contamination risks and simplify operations. However, they also lock healthcare into a linear materials model that conflicts with rising sustainability expectations.

You can also read: SABIC Makes Polycarbonate From Mixed Recycled Plastics.

Until recently, healthcare teams focused circularity efforts on low-risk plastics, such as non-hazardous packaging and bio-based materials. Most stakeholders considered the recovery and reuse of regulated, sterilized devices impractical. However, new research now challenges that assumption.

At ANTEC 2026, Pierre Moulinie, Head of Global Technical Marketing for Healthcare in the Engineering Plastics business at Covestro, addressed this issue directly. Drawing on more than 25 years of experience, he emphasized the growing convergence of material science, regulatory requirements, and sustainability targets.

Beyond Packaging: Closing the Loop on Devices

Magali Barbaroux and her colleagues conducted experimental work that challenges the assumption that single-use bioprocess equipment must remain linear in material terms.

In a study published in the Journal of Cleaner Production, the team demonstrated that polycarbonate (PC) from discarded small-scale bioreactor vessels can be mechanically recycled and reused in cell culture applications without compromising biological performance.

The researchers examined widely used laboratory systems, including vessels produced by Sartorius Stedim Biotech. They collected, decontaminated, and shredded the used devices under controlled conditions, then reprocessed the recovered PC into new post-consumer recycled (PCR) bioreactor components. This “same-to-same” recycling pathway moves beyond conventional healthcare recycling, which typically downcycles materials into non-critical applications.

What Recycled Polycarbonate Can—and Cannot—Do

The material results align with established polymer behavior. Mechanical recycling increases melt flow rate, indicating reduced molecular weight, and slightly lowers tensile properties compared to virgin resin.

However, the recycled material remains within functional tolerance for its intended application.

The biological findings carry significant weight. Using standardized ASTM-guided cell culture methods, the researchers found no major negative effects on Chinese hamster ovary (CHO) cell growth or productivity. In practical terms, the recycled material does not interfere with biological performance under laboratory conditions.

Polycarbonate chemistry plays a decisive role. Its aromatic backbone resists thermal and mechanical degradation, allowing multiple recycling cycles with manageable property loss. This intrinsic stability positions PC as a viable candidate for circular applications in regulated environments.

Environmental Gains vs. Operational Reality

The study supports sustainability claims with quantitative analysis. A screening life-cycle assessment shows that closed-loop recycling of polycarbonate bioreactors can reduce climate impact by up to 34% under high recovery scenarios. Even under conservative assumptions, around 15% material recovery, the system still delivers net environmental benefits compared to virgin resin and incineration.

However, processors must overcome significant operational barriers to realize these gains. They must establish reliable collection and segregation systems, validate sterilization protocols, and control contamination. Healthcare plastics operate within strict regulatory frameworks, including Good Manufacturing Practice (GMP) requirements, which complicate material reuse. Regulators will likely adopt recycled content in bioprocessing equipment gradually, with acceptance varying by application. Clinical and commercial manufacturing environments will face the highest level of scrutiny.

From Technical Feasibility to Strategic Choice

This research does not suggest that healthcare plastics are easy to recycle. Instead, it demonstrates that technical feasibility is no longer the primary barrier.

Barbaroux and her colleagues provide some of the first experimental evidence showing that teams can close the loop on regulated polycarbonate devices at laboratory scale without compromising performance.

As sustainability targets, recycled-content mandates, and extended producer responsibility policies expand, pressure will move beyond packaging into complex medical devices. The industry already has the technical capability to implement circular solutions. However, success will depend on system-level factors, including infrastructure, standardization, and regulatory alignment. The key question is no longer whether circularity is possible, but whether the industry will choose to scale it.